Alex Denner (Photo by: Mark Neuling/CNBC/NBCU Photo Bank via Getty Images)

Hunt for Russ­ian oli­garch’s bil­lions leads to biotech ac­tivist in­vestor Alex Den­ner’s fund — re­port

The glob­al drag­net be­ing thrown out to cap­ture bil­lions of dol­lars in Russ­ian oli­garch mon­ey has spot­light­ed the role of an ac­tivist in­vestor who’s spurred some of the most promi­nent re­or­ga­ni­za­tions in biotech.

Fol­low­ing a sto­ry in the Wall Street Jour­nal, the New York Times to­day flagged Alex Den­ner’s Saris­sa Cap­i­tal Man­age­ment as one of a long list of funds that have worked with a low-pro­file firm called Con­cord Man­age­ment. Ac­cord­ing to both news­pa­pers, Con­cord has steered mas­sive in­vest­ments from Russ­ian oli­garch Ro­man Abramovich — worth an es­ti­mat­ed $13 bil­lion — to a va­ri­ety of funds, in­clud­ing Saris­sa, while keep­ing the oli­garch’s name out of the trans­ac­tions.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters